Improving the treatment and lives of patients with blood cancer by supporting leading edge clinical trials
We are committed to supporting initiatives that improve health outcomes for blood cancer patients including improved access to new drugs that may be more effective than those currently available. One of the ways to do this is through clinical trials which are the pivotal step in a long process to prove the effectiveness and safety of potential new treatments discovered in the laboratory.
By participating in a clinical trial, patients can access potentially lifesaving treatments not currently available to them. If a clinical trial is successful, the drug can go on to become a new treatment option for patients in the wider community.